Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TACH101 |
Synonyms | |
Therapy Description |
TACH101 inhibits KDM4, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 3720). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TACH101 | TACH 101|TACH-101|QC8222|QC-8222|QC 8222 | KDM4 Inhibitor 4 | TACH101 inhibits KDM4, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 3720). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05076552 | Phase I | TACH101 | A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer | Active, not recruiting | USA | 0 |